Category: Regulatory Review

By Capitol Associates, Inc.
Lamar Alexander (R-TN), Chairman of the Senate Health, Education, Labor and Pensions Committee, believes that certain temporary federal telehealth policies should be made permanent. Chairman Alexander is focused on three main changes; provider reimbursement regardless of the originating site, Medicare and Medicaid reimbursement for telehealth services, and providing telehealth services through common apps like FaceTime or texting.

By Capitol Associates, Inc.
Results from a University of Oxford study showed that Dexamethasone, a commonly used steroid, reduces death in severe COVID-19 patients by up to one third. Scientists around the world are cautiously optimistic about the study but are remaining skeptical until they can review the research data.

By Capitol Associates, Inc.
The Department of Health and Human Services (HHS) announced a new Provider Relief Fund distribution of $15 billion dollars to Medicaid providers who did not receive funding from the Provider Relief Fund’s General Allocation. HHS is also distributing $10 billion to safety net hospitals.

By Capitol Associates, Inc.
The White House Coronavirus Taskforce does not see a link between an increase in Coronavirus cases and states reopening, but there are worries of a spike in COVID-19 cases related to ongoing protests in all 50 states.

By Capitol Associates, Inc.
National Institute of Allergy and Infectious Disease (NIAID) Director, Dr. Anthony Fauci believes the U.S. will have at least 100 million COVID-19 vaccines before the end of the year. He also believes we will have a few hundred million more vaccines by the beginning of 2021.